Christopher Posner
Chief Executive Officer chez CARA THERAPEUTICS, INC.
Fortune : 164 274 $ au 31/03/2024
Profil
Christopher A.
Posner is currently the President, Chief Executive Officer & Director at CARA Therapeutics, Inc. Prior to his current position, he served as the President & Chief Executive Officer at Leo Pharma, Inc. from 2017 to 2021.
He also held the position of Head-Worldwide Commercial Operations at R-Pharm US LLC from 2014 to 2017.
Mr. Posner has an undergraduate degree from Villanova University and an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CARA THERAPEUTICS INC
0,33% | 29/02/2024 | 180 521 ( 0,33% ) | 164 274 $ | 31/03/2024 |
Postes actifs de Christopher Posner
| Sociétés | Poste | Début |
|---|---|---|
| CARA THERAPEUTICS, INC. | Chief Executive Officer | 09/11/2021 |
Anciens postes connus de Christopher Posner
| Sociétés | Poste | Fin |
|---|---|---|
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Chief Executive Officer | 01/10/2021 |
R-Pharm US LLC
 R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/01/2017 |
| ZEVRA THERAPEUTICS, INC. | Director/Board Member | - |
Formation de Christopher Posner
| Villanova University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Health Technology |
